A new 12-membered macrolide, balticolid (1) was isolated from the EtOAc extract of the culture broth of fungal strain 222 belonging to the Ascomycota, which was found on driftwood collected from the coast of the Greifswalder Bodden, Baltic Sea, Germany. The structure of balticolid was determined to be (3R,11R), (4E,8E)-3-hydroxy-11-methyloxacyclododeca-4,8-diene-1,7-dione using extensive spectral data as well as the modified Mosher ester method. Balticolid (1) displayed anti-HSV-1 activity with an IC 50 value of 0.45 µM.
Introduction
Marine microorganisms are recognized as important sources of pharmacologically active metabolites [1] [2] [3] . In particular, a growing number of marine-derived fungi have been reported to produce novel bioactive secondary metabolites. In an earlier part of this chemical investigation we described the isolation and structure elucidation of several new antiviral naphthalenone derivatives from the EtOAc extract of an ascomycetous fungus [4] . On further investigation of this fungus, we OPEN ACCESS describe herein the isolation, structure elucidation and the biological activity of the novel 12-membered macrolide, balticolid (1) .
Fungal metabolites that contain twelve-membered lactone rings like recifeiolide from Cephalosporium recifei [5] , cladospolides A-C from Cladosporium cladosporioides [6] and Cladosporium tenuissimum [7] , patulolides A-C from Penicillium urticae [8, 9] , pandangolides 1-4 from Cladosporium herbarum [10] and chloriolide from Chloridium virescens var. chlamydosporum [11] have already been reported.
Results and Discussion
Balticolid (1) was obtained as colorless oil. Its molecular formula was determined to be C 12 Figure 2 . These findings were also supported by cross peaks in ROESY spectrum and difference NOEs experiments. Furthermore, the absolute configuration of balticolid (1) at C-3 was deduced by modified high-field 1 H NMR Mosher method [12] [13] [14] . In order to determine the absolute configuration at C-3, balticolid (1) was treated with (R) and (S)-α-methoxy-α-trifluoromethyl-phenylacetyl chloride (MTPA-Cl) in the presence of 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide to give the (S)-and (R)-MTPA esters respectively. In the 1 H NMR spectrum of the (S)-MTPA ester, the proton signals assigned to H-2a, and H-2b were observed at a higher field than those of the (R)-MTPA ester, and H-4, H-5, H-6a and H-6b were observed at a lower field than those of the (R)-MTPA ester. The bulk effect on chemical shifts induced by esterification with the chiral reagents was calculated using Δδ = (δ S − δ R ), where δ S and δ R are the shifts (in ppm) of diagnostic protons neighboring the chiral center in balticolid (1) of the (S) and (R) Mosher's esters respectively. The absolute configuration of 1 was obtained by positioning the protons with positive Δδ values on the right side and those with negative Δδ values on the left side in the model described by Ohtani et al. [13] which clearly showed that the absolute configuration at C-3 was R (Figure 3) . The relative configuration of 1 at C-11 was elucidated from the interactions observed in difference NOEs experiments. By applying a decoupling field to methine proton H-8 (δ H 5.99) there was enhancement of H-5 (δ H 5.75), H-6a (δ H 3.43) and H-10a (δ H 2.52) indicating that these protons are situated on the same face while H-6b is on the opposite face. Furthermore, enhancement of proton H-4 (δ H 5.73) and H-11 (δ H 5.11) upon irradiation of H-2b (δ H 2.68) and H-9 (δ H 6.78) were observed respectively ( Figure 2 ) indicating that these protons are situated on the opposite face or β-oriented in 1. Therefore, the absolute configurations of both chiral centers of 1 were assigned as 3R, 11R. b Chemical shifts ( δ ) were expressed in ppm, J in Hz.
c Implied multiplicities were determined by DEPT (C = s, CH = d, CH 2 = t).
Compound 1 was tested at non-cytotoxic concentrations for antiviral activity against influenza A virus and Herpes simplex virus (HSV) type I. Balticolid was only found to exhibit inhibitory activity against herpes simplex virus with an IC 50 value of 0.45 µM compared to 0.44 µM/aciclovir. The compound showed no remarkable antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida maltosa at 200 µg/disc in the agar-diffusion assay. Further structural modifications to optimize physico-chemical properties, by total and semi-synthetic approach could result in more potent molecules with desirable pharmacokinetic properties. Thorough structure activity relationship (SAR) studies of balticolid derivatives might result in new drug-lead candidates which can be exploited as future drugs. with an ultra-performance LC system (Accela; Thermo-Fisher, Germany) coupled via automated chip-based nanoelectrospray (NanoMate; Advion, UK) to the LTQ-Orbitrap mass spectrometer (Thermo-Fisher).
Strain and Fermentation
The strain 222 was isolated from driftwood collected in November 2002 from the coast of Greifswalder Bodden, Baltic Sea, Germany, by G. Mernitz and B. Cuypers. The material was classified by A. W. A. M. de Cock, Centraalbureau voor Schimmelcultures, Fungal Biodiversity Centre, Utrecht, The Netherlands, and M. Unterseher, University Greifswald, Institute for Botany and Landscape Ecology, Greifswald, Germany, as a member of the order Pleosporales, Ascomycota, by ITS sequence (accession number in the European Nucleotide Archive FR852578). Since the isolate remained sterile in subcultures on different media an exact taxonomic determination was not possible. The culture has been deposited in the culture collection of the Department of Pharmaceutical Biology, University of Greifswald (Voucher number 222). Fermentation was carried out in liquid shake cultures. 500 mL Erlenmeyer flasks containing 200 mL of Hagem medium (ammonium succinate 0.5 g; KH 2 PO 4 0.5 g; MgSO 4 7H 2 O 0.5 g; FeCl 3 (1%) 0.5 mL; glucose 5 g; malt extract 5.0 g; aqua purificata 1000 mL, pH 7.5) were inoculated with a homogenized pre-culture of a mycelial culture of the strain 222 and cultivated on a rotary shaker (125 rpm) for 19 days at room temperature.
Extraction and Isolation
Mycelium and fermentation broth were separated and the culture broth was extracted with EtOAc. The organic layer was dried with anhydrous sodium sulfate and then concentrated in vacuum using a rotary evaporator to give a brown residue (500 mg from 11 L of culture broth). The extract was fractionated by CC (system 1) to yield seven fractions (A-G) according to chemical monitoring by TLC. Fraction D (70 mg) was further subjected to CC (system 2) and 8 fractions (D1-D8) were separated through TLC guided fractionation. Fraction D4 was further purified by RP-HPLC to yield 6.5 mg of balticolid (1). 
Balticolid

Preparation of (S)-and (R)-MTPA Esters of Balticolid (1)
Two portions (1.5 mg each) of 1 were dissolved in dry CH 2 Cl 2 (1 mL) containing 1 mg of dimethylaminopyridine and eight equivalents of dicyclohexylcarbodiimide. Six equivalents of either the (S) or the (R) isomer of α-methoxy-α-trifluoromethylphenylacetyl chloride were added to a portion of 1. The reaction mixtures were allowed to stand for 24 h at room temperature. The reaction was quenched by addition of 1.0 mL of water, and the mixture was subsequently extracted with Et 2 O (3 × 1.0 mL). The Et 2 O soluble layers were combined, dried over anhydrous MgSO 4 and evaporated. The residue was subjected to column chromatography over silica gel using n-hexane-EtOAc 
Biological Activities
An agar diffusion assay according to the European Pharmacopoeia [12] was used to determine antibacterial and antifungal activity. Ampicillin was used as positive control. The following test strains were used: Staphylococcus aureus ATCC 6538, Escherichia coli ATCC 11229, and Candida maltosa SBUG 700. The compound was tested for antiviral activity against influenza A virus and Herpes simplex virus (HSV) type I using a test system as described by Shushni et al. [4] . Briefly, the virus-host systems influenza A virus-Madine-darby canine kidney (MDCK) cells and Herpes simplex virus-African green monkey kidney (Vero) cells were used. Confluent monolayers of the cells were pre-incubated treated with different concentrations of balticolid or reference compounds amantadine and acyclovir in four replicates for 30 min at 37 °C. MDCK cells were infected with 30 TCID 50 (tissue culture infectious dose leading to virus infection of 50% of the cells) of influenza virus A and Vero cells with 30 TCID 50 of HSV-I and further incubated for 72 h at 37 °C. The antiviral effect of test compounds was determined by neutral red assay in comparison to infected cells without test compound and non infected cells. Before antiviral tests a possible cytotoxicity of balticolid for MDCK and Vero cells was measured also by the neutral red assay. Only non-cytotoxic concentrations were used for the antiviral tests.
